| Literature DB >> 30526510 |
Henshaw Uchechi Okoroiwu1, Francisco López-Muñoz2,3,4,5, F Javier Povedano-Montero2,6.
Abstract
BACKGROUND: Lassa fever has been a public health concern in the West African sub-region where it is endemic and a latent threat to the world at large. We investigated the trend in Lassa fever research using bibliometric approach.Entities:
Keywords: Bibliometric analysis; Lassa; Lassa fever; Lassa research
Mesh:
Year: 2018 PMID: 30526510 PMCID: PMC6288929 DOI: 10.1186/s12879-018-3526-6
Source DB: PubMed Journal: BMC Infect Dis ISSN: 1471-2334 Impact factor: 3.090
Contributing literature type
| Document type | No of documents | % |
|---|---|---|
| Article | 745 | 67.67 |
| Review | 191 | 17.35 |
| Letter | 54 | 4.90 |
| Editorial | 25 | 2.27 |
| Note | 23 | 2.09 |
| Short Survey | 20 | 1.82 |
| Book Chapter | 19 | 1.73 |
| Conference Paper | 13 | 1.18 |
| Article in Press | 5 | 0.45 |
| Erratum | 4 | 0.36 |
| Book | 2 | 0.18 |
Fig. 1Chronological distribution of scientific literature on Lassa fever within the study period. b Linear trendline. a Exponential trendline
Fig. 2Temporal evolution of publication in Lassa fever. . Production doubles every 9.19 years
Classification of authors based on productivity
| NP ≥ 1 | 0 < NP < 1 | NP = 0 | Total | |
|---|---|---|---|---|
| Number of authors | 38 | 633 | 2508 | 3179 |
| % Authors | 1.20 | 19.91 | 78.89 | 100.00 |
Bradford division of journals
| No of journals | % of journals | No of articles | % of articles | Bradford multiplier | |
|---|---|---|---|---|---|
| Core | 19 | 4.34 | 372 | 33.79 | |
| Zone 1 | 74 | 16.89 | 332 | 30.15 | 3.89 |
| Zone 2 | 345 | 78.77 | 397 | 36.06 | 4.66 |
| Total | 438 | 100.00 | 1101 | 100.00 | 4.27 |
Fig. 3Bradford distribution, global data
Analysis of collaboration among authors
| Signing authors | No. Of documents | Aggregate | Documents (%) |
|---|---|---|---|
| 84 | 1 | 84 | 0.091 |
| 72 | 1 | 72 | 0.091 |
| 51 | 1 | 51 | 0.091 |
| 50 | 1 | 50 | 0.091 |
| 35 | 2 | 70 | 0.182 |
| 33 | 1 | 33 | 0.091 |
| 31 | 1 | 31 | 0.091 |
| 30 | 1 | 30 | 0.091 |
| 27 | 1 | 27 | 0.091 |
| 26 | 1 | 26 | 0.091 |
| 25 | 2 | 50 | 0.182 |
| 22 | 2 | 44 | 0.182 |
| 20 | 2 | 40 | 0.182 |
| 19 | 2 | 38 | 0.182 |
| 18 | 3 | 54 | 0.272 |
| 17 | 2 | 34 | 0.182 |
| 16 | 6 | 96 | 0.545 |
| 15 | 8 | 120 | 0.727 |
| 14 | 8 | 112 | 0.727 |
| 13 | 13 | 169 | 1.181 |
| 12 | 18 | 216 | 1.635 |
| 11 | 17 | 187 | 1.544 |
| 10 | 31 | 310 | 2.816 |
| 9 | 35 | 315 | 3.179 |
| 8 | 33 | 264 | 2.997 |
| 7 | 42 | 294 | 3.815 |
| 6 | 71 | 426 | 6.449 |
| 5 | 74 | 370 | 6.721 |
| 4 | 104 | 416 | 9.446 |
| 3 | 134 | 402 | 12.171 |
| 2 | 148 | 296 | 13.442 |
| 1 | 335 | 335 | 30.427 |
Analysis of the top 10 sources with the largest number of publicationsa
| Source | No of documents | Productivity Index | Impact Factor | Country of origin | Abbreviated Journal Title |
|---|---|---|---|---|---|
|
| 51 | 4.63 | 4.663 | United States | J. Virol. |
|
| 27 | 2.45 | 2.279 | England | Roy. Soc. Trop. Med. Hyg. |
|
| 25 | 2.27 | 0.160b | Russia | Vopr. Virusol. |
|
| 24 | 2.18 | 2.549 | United States | Am. J. Trop. Med. Hyg. |
|
| 24 | 2.18 | 4.939 | Switzerland | Bull. World Health Organ. |
|
| 24 | 2.18 | 8.222 | United States | Emerg. Infect. Dis |
|
| 22 | 2.00 | 47.831 | England | Lancet |
|
| 20 | 1.82 | 20.785 | England | BMJ – Br. Med. J. |
|
| 20 | 1.82 | 6.273 | United States | J. Infect. Dis. |
|
| 20 | 1.82 | 3.834 | United States | Plos Neglect. Trop. Dis. |
aData from the Journal Citation Report
bData 1998
Top 20 most productive countries in Lassa fever research
| Country | No of documents | % |
|---|---|---|
| United States | 450 | 40.87 |
| Undefined | 261 | 23.71 |
| United Kingdom | 117 | 10.63 |
| Germany | 96 | 8.72 |
| Nigeria | 65 | 5.90 |
| Sierra Leone | 54 | 4.90 |
| France | 44 | 4.00 |
| Canada | 32 | 2.91 |
| Switzerland | 32 | 2.91 |
| Netherlands | 22 | 2.00 |
| Guinea | 21 | 1.91 |
| Japan | 21 | 1.91 |
| Sweden | 18 | 1.63 |
| South Africa | 17 | 1.54 |
| Belgium | 16 | 1.45 |
| Italy | 12 | 1.09 |
| Liberia | 12 | 1.09 |
| Australia | 10 | 0.91 |
| India | 10 | 0.91 |
| China | 9 | 0.82 |
Relationship between production of scientific literature on Lassa fever and total production in some fields of infectious diseases in world 10 most productive countries in biomedical and health sciences
| Country | IPa Medicineb | IP Health Professionsa | IP Pharmacology, Toxicology and Pharmaceuticsa | IP Lassa Feverc | IP Tuberculosisb | IP AIDSb |
|---|---|---|---|---|---|---|
| United States | 25.51 | 49.80 | 15.01 | 40.87 | 18.38 | 33.76 |
| United Kingdom | 8.07 | 14.43 | 4.14 | 10.63 | 8.04 | 7.43 |
| Germany | 6.10 | 1.36 | 3.17 | 8.72 | 3.78 | 3.81 |
| China | 5.86 | 0.39 | 1.,37 | 0.82 | 3.25 | 3.17 |
| Japan | 4.29 | 0.65 | 3.12 | 1.91 | 4.29 | 2.12 |
| France | 3.84 | 0.66 | 1.71 | 4.00 | 4.50 | 3.72 |
| Canada | 3.64 | 6.27 | 1.44 | 2.91 | 2.22 | 3.32 |
| Italy | 3.08 | 0.74 | 1.95 | 1.09 | 2.84 | 2.93 |
| Australia | 2.79 | 5.91 | 1.18 | 0.91 | 1.53 | 2.43 |
| Spain | 2.78 | 0.65 | 1.34 | 0.64 | 2.87 | 2.10 |
aParticipation Index
bScimago Journal & Country Rank
cData 1970–2017
Top 20 most productive institutions in Lassa fever research
| Instiution | Country of residence | No of documents | % |
|---|---|---|---|
| Centers for Disease Control and Prevention | USA | 113 | 10.26 |
| Bernhard Nocht Institut fur Tropenmedizin Hamburg | Germany | 61 | 5.54 |
| U.S. Army Medical Research Institute of Infectious Diseases | USA | 53 | 4.81 |
| Scripps Research Institute | USA | 52 | 4.72 |
| UT Medical Branch at Galveston | USA | 44 | 4.00 |
| National Center for Infectious Diseases | USA | 34 | 3.09 |
| National Institutes of Health. Bethesda | USA | 31 | 2.82 |
| Tulane University | USA | 28 | 2.54 |
| UCL (University College London) | UK | 27 | 2.45 |
| Kenema Government Hospital | Sierra Leone | 24 | 2.18 |
| Institute of Human Virology | Nigeria | 22 | 2.00 |
| University of Ibadan | Nigeria | 18 | 1.63 |
| Universitat Marburg | Germany | 18 | 1.63 |
| Irrua Specialist Teaching Hospital | Nigeria | 16 | 1.45 |
| Tulane University School of Public Health and Tropical Medicine | USA | 15 | 1.36 |
| National Center for Emerging and Zoonotic Infectious Diseases | USA | 15 | 1.36 |
| Zalgen Labs | USA | 14 | 1.27 |
| Emory University | USA | 14 | 1.27 |
| Institut Pasteur Paris | France | 14 | 1.27 |
| Viral and Rickettsial Zoonoses Br. | USA | 14 | 1.27 |
Top 6 authors with the most publications related to Lassa fever
| Author | No of Documents | % Documents | h-index | Country | Afiliattion | Cited | % Cited | Article/cited |
|---|---|---|---|---|---|---|---|---|
| McCormick J.B. | 39 | 3.54 | 56 | United States | University of Texas Health Science Center at Houston | 2174 | 9.40 | 55.74 |
| Günther S. | 35 | 3.18 | 53 | Germany | Bernhard Nocht Institut fur Tropenmedizin Hamburg | 1329 | 5.75 | 37.97 |
| Garry R.F. | 31 | 2.82 | 37 | United States | Zalgen Labs. Germantown | 523 | 2.26 | 16.87 |
| Salvato M.S. | 25 | 2.27 | 32 | United States | University of Maryland | 748 | 3.23 | 29.92 |
| Lukashevich I.S. | 22 | 2.00 | 24 | United States | Center for Predictive Medicine for Biodefense and Emerging Infectious Diseases | 806 | 3.49 | 36.64 |
| Grant D.S. | 20 | 1.82 | 12 | United States | Zalgen Labs | 265 | 1.15 | 13.25 |
Top 10 most cited articles
| Article | Authors | Source | Cited | % |
|---|---|---|---|---|
| Legionnaires’ Disease: Description of an Epidemic of Pneumonia | Fraser, D.W., Tsai, T.R., Orenstein, W., (...), Shepard, C.C., Brachman, P.S. |
| 1071 | 4.63 |
| Lassa Fever | McCormick, J.B., King, I.J., Webb, P.A., (...), Elliott, L.H., Belmont-Williams, R. |
| 549 | 2.37 |
| Identification of α-dystroglycan as a receptor for lymphocytic choriomeningitis virus and Lassa fever virus | Cao, W., Henry, M.D., Borrow, P., (...), Campbell, K.P., Oldstone, M.B.A. |
| 429 | 1.86 |
| Social and environmental risk factors in the emergence of infectious diseases | Weiss, R.A., McMichael, A.J. |
| 305 | 1.32 |
| Rodent-borne diseases and their risks for public health | Meerburg, B.G., Singleton, G.R., Kijlstra, A. |
| 256 | 1.11 |
| Importance of Aeromonas Sobria in Aeromonas Bacteremia | Janda, J.M., Brenden, R. |
| 252 | 1.09 |
| The small RING finger protein Z drives arenavirus budding: Implications for antiviral strategies | Perez, M., Craven, R.C., De la Torre, J.C. |
| 218 | 0.94 |
| Molecular mechanisms of action of ribavirin | Patterson, J.L., Fernandez-Larsson, R. |
| 217 | 0.94 |
| Prospects for Treatment of Viral Hemorrhagic Fevers with Ribavirin, a Broad-Spectrum Antiviral Drug | Huggins, J.W. |
| 209 | 0.90 |
| Lassa fever | McCormick, J.B., Fisher-Hoch, S.P. |
| 192 | 0.83 |